Psoriasiform reactions during treatment with abatacept

Indian Journal of Dermatology, Venereology and Leprology

Volumn 80, Issue 1, 2014, Pages 92-93

  Conde Montero, Elena ^a   Baniandrés Rodríguez, Ofelia ^a   Mendoza Cembranos, María ^a   Horcajada Reales, Celia ^a   Suárez Fernández, Ricardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIRHEUMATIC AGENT;

ADULT; CASE REPORT; CHEMICALLY INDUCED; DISEASE COURSE; DRUG ERUPTIONS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PSORIASIS;

ABATACEPT; ADULT; ANTIRHEUMATIC AGENTS; DISEASE PROGRESSION; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS;

EID: 84894206087     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.125502     Document Type: Letter

References (5)

1. de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007;143:223-31.
2. Brunasso AM, Laimer M, Massone C. Paradoxical reactions to targeted biological treatments: A way to treat and trigger? Acta Derm Venereol 2010;90:183-5.
3. Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009;161:1081-8.
4. Konsta M, Rallis E, Karameris A, Stratigos A, Sfikakis PP, Iliopoulos A. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation. J Eur Acad Dermatol Venereol 2012;26:257-8.
5. Kato K, Satoh T, Nishizawa A, Yokozeki H. Psoriasiform drug eruption due to abatacept. Acta Derm Venereol 2011;91:362-3.